Product Information

EVEROLIMUS 5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $14.7708 per EA under NDC 72603025501. Its NADAC has been published 77 times since Mar 5, 2025.

FDA first approved this application on Feb 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EVEROLIMUS 5 MG TABLET

everolimus
$14.7708per EA

Strength

5 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603025501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

4/22/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA214182

FDA Approved

2/11/2021

TE Code

AB

On Market Since

10/1/2024

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for EVEROLIMUS 5 MG TABLET has been published 77 times since Mar 5, 2025, and over the history we have for it it has declined 19.0%. The table below summarizes its recorded NADAC range and movement.

Current price$14.7708 per EA
All-time high$18.2408 (Apr 16, 2025)
All-time low$14.7708 (Dec 17, 2025)
52-week high$17.5117
52-week low$14.7708
Median price$17.5117
Average price$16.2965
Largest weekly change-15.7% (Dec 17, 2025)
Weeks tracked77
Tracking sinceMar 5, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-15.7%

3Y

N/A

5Y

N/A

All

-19.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of EVEROLIMUS 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 5 MG TABLET, manufactured by NorthStar Rx LLC, is $14.7708 per EA (NDC 72603025501), effective Aug 19, 2026.

How has the price of EVEROLIMUS 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for EVEROLIMUS 5 MG TABLET has declined 19.0%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for EVEROLIMUS 5 MG TABLET?

Since Mar 5, 2025, the NADAC for EVEROLIMUS 5 MG TABLET has ranged from a low of $14.7708 (Dec 17, 2025) to a high of $18.2408 (Apr 16, 2025), with a median of $17.5117 per EA.

Are there cheaper alternatives to EVEROLIMUS 5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EVEROLIMUS 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures EVEROLIMUS 5 MG TABLET?

EVEROLIMUS 5 MG TABLET (NDC 72603025501) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.